MetLife Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.53M	Sell	68,672 -1,793	-3%	-$42.8K	0.01%	1199
2025 Q4	$1.88M	Sell	70,465 -3,647	-5%	-$87.2K	0.01%	1102
2025 Q3	$1.58M	Buy	+74,112	New	+$1.75M	0.01%	1217
2025 Q2	–	Sell	-71,835	Closed	-$1.19M	–	2732
2025 Q1	$1.19M	Sell	71,835 -1,213	-2%	-$22K	0.01%	1274
2024 Q4	$1.34M	Buy	73,048 +2,669	+4%	+$43.1K	0.01%	1266
2024 Q3	$1.08M	Hold	70,379	–	–	0.01%	1348
2024 Q2	$1.14M	Buy	70,379 +6,624	+10%	+$107K	0.01%	1274
2024 Q1	$1.18M	Hold	63,755	–	–	0.01%	1213
2023 Q4	$2M	Hold	63,755	–	–	0.01%	944
2023 Q3	$1.33M	Hold	63,755	–	–	0.01%	1090
2023 Q2	$1.53M	Hold	63,755	–	–	0.01%	1048
2023 Q1	$1.2M	Sell	63,755 -2,596	-4%	-$49.4K	0.01%	1135
2022 Q4	$1.06M	Hold	66,351	–	–	0.01%	1189
2022 Q3	$1.09M	Hold	66,351	–	–	0.01%	1141
2022 Q2	$935K	Hold	66,351	–	–	0.01%	1242
2022 Q1	$1.61M	Buy	66,351 +23,265	+54%	+$563K	0.01%	1082
2021 Q4	$1.01M	Hold	43,086	–	–	0.01%	1118
2021 Q3	$716K	Hold	43,086	–	–	0.01%	1315
2021 Q2	$1.05M	Buy	+43,086	New	+$973K	0.01%	1136
2020 Q2	–	Sell	-48,173	Closed	-$2.04M	–	2296
2020 Q1	$2.04M	Hold	48,173	–	–	0.03%	601
2019 Q4	$2.06M	Buy	48,173 +2,065	+4%	+$89.8K	0.02%	799
2019 Q3	$1.66M	Sell	46,108 -3,563	-7%	-$108K	0.02%	856
2019 Q2	$1.33M	Hold	49,671	–	–	0.01%	984
2019 Q1	$1.33M	Buy	49,671 +3,852	+8%	+$90K	0.01%	964
2018 Q4	$741K	Hold	45,819	–	–	0.01%	1147
2018 Q3	$951K	Hold	45,819	–	–	0.01%	1151
2018 Q2	$700K	Buy	+45,819	New	+$817K	0.01%	1202